---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-030517"
form_type: "8-K"
ticker: "GYRE"
cik: "0001124105"
company_name: "GYRE THERAPEUTICS, INC."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T20:36:16.330179+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Catalyst creates super-voting Series Y Preferred to ensure reverse stock split approval

## Summary
- Board declared dividend of one one-thousandth of a share of Series Y Preferred for each common share, record date June 30, 2023.
- Each one-thousandth of a share of Series Y Preferred entitles holder to 250 votes, but only on a reverse stock split proposal.
- Series Y Preferred cannot be transferred separately from common shares, and will be redeemed at $0.001 per whole share after the vote.
- Series Y Preferred ranks senior to common but junior to Series X Preferred and CVRs; no dividend rights, only liquidation preference of $0.001 per share.

## SEC filing metadata
- accession: 0001140361-23-030517
- form_type: 8-K
- ticker: GYRE
- cik: 0001124105
- company_name: GYRE THERAPEUTICS, INC.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124105/000114036123030517/0001140361-23-030517-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124105/000114036123030517/brhc20054638_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-030517
- JSON: https://secwatch.observer/filing/0001140361-23-030517.json
- Plain text: https://secwatch.observer/filing/0001140361-23-030517.txt

## Key facts
- Governance Changes
  GYRE THERAPEUTICS, INC.: Filed a Certificate of Designation for Series Y Preferred Stock, setting forth rights, preferences, and limitations in connection with a Reverse Stock Split amendment to the Certificate of Incorporation (effective 2023-06-20).
  - Change: charter amendment
  - Effective: 2023-06-20
  source text: The Company has filed a certificate of designation with respect to the Series Y Preferred Stock (the “Certificate of Designation”) that sets forth the rights, preferences and limitations of the Series Y Preferred Stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1124105/000114036123030517/0001140361-23-030517-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.